Merck Settles Class Suit Targeting Coppertone Claims, Denies Wrongdoing
This article was originally published in The Rose Sheet
Executive Summary
Merck agrees to pay a maximum of $10 million to consumers to settle class-action litigation. Firm’s compliance with sunscreen labeling and claims requirements that will become law in December under an FDA final rule satisfies plaintiffs, who took issue with past Coppertone claims that allegedly overstated products’ sun-protective benefits. The settlement in federal court resolves separate litigation against Coppertone filed in California state court.